US EditionLiquidia Tightens 340B Contract Pharmacy Restrictions; Biogen, Sanofi Exempt New States - 340B Report
Summary by 340breport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Liquidia Tightens 340B Contract Pharmacy Restrictions; Biogen, Sanofi Exempt New States - 340B Report
A North Carolina-based drugmaker recently tightened its 340B contract pharmacy restrictions to limit distribution of a pulmonary arterial hypertension treatment—just [...] The post Liquidia Tightens 340B Contract Pharmacy Restrictions; Biogen, Sanofi Exempt New States appeared first on 340B Report.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
